Pub. Date : 2015 Dec 7
PMID : 26639561
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | These data suggest that the combination of EGFR TKI with mTOR or PDE4 inhibitors could be adequate therapy for EGFR-mutant NSCLC patients with high pretreatment levels of BIM and mTOR. | bim | mechanistic target of rapamycin kinase | Homo sapiens |